Amy Rayo

Title: Amy Rayo - Innovator in CD19 Binding Molecules

Introduction

Amy Rayo is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of CD19 binding molecules. Her work has the potential to impact the treatment of various diseases associated with CD19 expression.

Latest Patents

Amy Rayo holds 1 patent for her invention titled "CD19 binding molecules and uses thereof." This patent provides detailed information about CD19 binding molecules that specifically bind to CD19. It includes monospecific, bispecific, and trispecific binding molecules, as well as conjugates and pharmaceutical compositions that utilize these binding molecules. The patent also outlines methods for using these molecules to treat diseases and disorders linked to CD19 expression. Furthermore, it describes recombinant host cells engineered to express the CD19 binding molecules and methods for producing these molecules through cell culture.

Career Highlights

Amy Rayo is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to work on innovative solutions that address critical health challenges. Her expertise in biotechnology and her focus on CD19 binding molecules highlight her commitment to advancing medical science.

Collaborations

Amy collaborates with talented professionals in her field, including Brian Walter Granda and Connie Hong. These collaborations enhance her research and contribute to the development of groundbreaking therapies.

Conclusion

Amy Rayo is a dedicated inventor whose work on CD19 binding molecules represents a significant advancement in biotechnology. Her contributions have the potential to lead to new treatments for diseases associated with CD19 expression.